Detected ·
RQ Biotechnology Ltd.
$115M—
RQ Biotechnology Ltd. raised $115M in Series A financing led by Frazier Life Sciences, with participation from Forbion, EQT Life Sciences, Monograph Capital, Wellington Management, and founding investor LifeArc Ventures. The funding will support RQB01, a long-acting antibody for influenza prophylaxis, toward clinical trials.
- Website
- www.rqbiotechnology.com
- Amount
- $115 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-06-24 08:04:38 UTC
- Signal ID
- b247e808-d8fb-4803-9b67-b697c45802bf
As the API returns it
{
"id": "b247e808-d8fb-4803-9b67-b697c45802bf",
"created_at": "2026-06-24T08:04:38.372505Z",
"company_name": "RQ Biotechnology Ltd.",
"company_website_url": "www.rqbiotechnology.com",
"company_linkedin_url": "https://www.linkedin.com/company/rq-biotechnology-ltd",
"event_type": "funding",
"funding_amount": 115000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*RQ Biotechnology Ltd. raised $115M in Series A financing led by Frazier Life Sciences, with participation from Forbion, EQT Life Sciences, Monograph Capital, Wellington Management, and founding investor LifeArc Ventures. The funding will support RQB01, a long-acting antibody for influenza prophylaxis, toward clinical trials.*"
}